CB Therapeutics is producing cannabinoids for use as nutraceuticals, topical treatments, cosmetics, food and beverage and in animal-health. Our biosynthetic production method in yeast, delivers cannabinoids that are identical to those extracted from plants, such as cannabis or hemp. But our cannabinoids are pure, consistent, not contaminated by insecticides or other chemical or organic material for biopharmaceutical testing and clinical research.